Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Quinones

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Advances in Therapy|April 29, 2005
The efficacy of bimatoprost 0.03% monotherapy in patients previously using topical beta-blocker monotherapy for the treatment of glaucoma or ocular hypertensionRichard Quinones, Melissa L Earl
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 1, 2004
Efficacy of bimatoprost 0.03 percent in untreated glaucoma and ocular hypertension patients: results from a large community-based clinical trialRichard Quinones, Todd Severin, Thomas Mundorf
Journal of Glaucoma|June 5, 2003
Angle-closure glaucoma in teenagersVandana K Badlani, Richard Quinones, Jacob T Wilensky, et al.
Journal of Glaucoma|April 15, 2009
Predicted refraction versus refraction outcome in cataract surgery after trabeculectomyMarcus S Muallem, Gregory A Nelson, Smajo Osmanovic, et al.
European Journal of Ophthalmology|March 3, 2021
Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucomaAmy A Mehta, Levi N Kanu, Shalini Sood-Mendiratta, et al.
Micropublication Biology|June 24, 2026
Functional Annotation of FD Cluster Phage Bouclier that Infects <i>Arthrobacter globiformis</i>Matias Espinosa, Hannah Atchley, Kaden K Bambach, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Advances in Therapy|April 29, 2005
The efficacy of bimatoprost 0.03% monotherapy in patients previously using topical beta-blocker monotherapy for the treatment of glaucoma or ocular hypertensionRichard Quinones, Melissa L Earl
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 1, 2004
Efficacy of bimatoprost 0.03 percent in untreated glaucoma and ocular hypertension patients: results from a large community-based clinical trialRichard Quinones, Todd Severin, Thomas Mundorf
Journal of Glaucoma|June 5, 2003
Angle-closure glaucoma in teenagersVandana K Badlani, Richard Quinones, Jacob T Wilensky, et al.
Journal of Glaucoma|April 15, 2009
Predicted refraction versus refraction outcome in cataract surgery after trabeculectomyMarcus S Muallem, Gregory A Nelson, Smajo Osmanovic, et al.
European Journal of Ophthalmology|March 3, 2021
Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucomaAmy A Mehta, Levi N Kanu, Shalini Sood-Mendiratta, et al.
Micropublication Biology|June 24, 2026
Functional Annotation of FD Cluster Phage Bouclier that Infects <i>Arthrobacter globiformis</i>Matias Espinosa, Hannah Atchley, Kaden K Bambach, et al.
Pageof 1